Skip to main content

Serum or Plasma (and Which Plasma), That Is the Question.

Vignoli A, Tenori L, Morsiani C, Turano P, Capri M, Luchinat C

Publication: J Proteome Res (2022) • Vol 21 • Page 1061-1072PMID: 35271285View on PubMed

Purpose

This paper used nuclear magnetic resonance spectroscopy to compare levels of 24 metabolites and 112 lipoproteins in case-matched K3EDTA plasma, citrated plasma and serum from 6 healthy individuals.

Conclusion

 

The NMR spectra showed the expected peaks in K3EDTA plasma (2.5-3.6 ppm from free K3EDTA and chelated EDTA) and citrated plasma (2.6 ppm multiplet from citrate). While the authors state that generally serum has no peaks associated with tube additives, separator gels and clotting agents produce NMR signals although they have a negligible effect on the metabolic fingerprint. In unsupervised PCA based on levels of the 24 metabolites, specimens clustered by tube type with the largest difference observed between citrate plasma and serum. However, clustering based on lipoproteins levels did not show clear clustering based on tube type. Of the 24 metabolites evaluated, 18 were significantly affected by tube type and 46 of the 112 lipoproteins were reduced in citrated plasma compared to either K3EDTA plasma or serum. The strength of correlations among levels of metabolites, but not lipoproteins, depended upon specimen type.  The authors developed a statistical solution based on regression analysis that once applied partially corrected for tube type-specific differences, which allowed specimens to cluster by individual.

Studies (1)

Purpose

This study used NMR spectroscopy to compare levels of 24 metabolites and 112 lipoproteins in case-matched K3EDTA plasma, citrated plasma and serum from 6 healthy individuals. Blood was collected from 4 healthy women (26-36 years old) and 2 healthy men (28 and 35 years old) up to five times over the course of 6 months (during weeks 0, 2, 4, 27 and 29).  At each time point blood was collected into Greiner Bio-One Serum tubes with gel separator and clot activator, K3EDTA plasma vacutainer tubes, and trisodium citrate plasma vacutainer tubes. Serum tubes were allowed to clot upright at room temperature for 30-60 min before serum separation by centrifugation at 794 g for 20 min at 4°C. Plasma was obtained by centrifugation at 2000 g for 20 min at 4°C. Serum and plasma were transferred to cryovials and frozen at -80°C within 2 h of blood collection.  Metabolite and lipoprotein levels were measured in serum and plasma by NMR. In total, 34 metabolites and 112 lipoproteins were identified and quantified from the NMR spectra using the Bruker IVDr Quantification in Plasma/Serum B.I.Quant-PS and IVDr Lipoprotein Subclass Analysis platforms, respectively.

Summary of Findings

The NMR spectra showed the expected peaks in K3EDTA plasma (2.5-3.6 ppm from free K3EDTA and chelated EDTA) and citrated plasma (2.6 ppm multiplet from citrate). While the authors state that generally serum does not have peaks associated with tube additives, the separator gels and clotting agents produced NMR signals, but these had a negligible effect on the metabolic fingerprint. In unsupervised PCA based on levels of the 24 metabolites, specimens clustered by tube type with the largest difference observed between citrate plasma and serum. Further analysis revealed that 18 of the 24 metabolites were significantly affected by tube type. Serum had higher levels of nine amino acids (alanine, glutamine, glycine, histidine, leucine, N,N-dimethylglycine, phenylalanine, tyrosine, and valine),  and lactate and lower levels of pyruvate, acetone, acetic acid, and formic acid than plasma (citrate or K3EDTA). Citrate plasma had lower levels of creatinine than serum, and lower levels of trimethylamine-N-oxide and sarcosine than K3EDTA plasma, and lower levels of GlycA and GlycB than both serum and K3EDTA plasma.  Correlations among levels of metabolites were dependent on tube type. Unlike the NMR results for metabolites, PCA based on lipoprotein levels did not show clear clustering based on collection tube type.  Nine specimens were found to be outliers, 6 of these were the specimens collected from a male patient at week 0 and 2, and the other 3 outliers were from the other male patient collected at week 0. Overall, citrate plasma had lower levels of 46 of the 112 lipoproteins evaluated than either K3EDTA plasma or serum. However, citrate plasma had higher levels of five lipoproteins (triglycerides LDL-3, triglycerides VLDL-5, cholesterol VLDL-5, free cholesterol VLDL-5, and phospholipids VLDL-5) than serum and higher levels of five lipoproteins (free cholesterol LDL-2, cholesterol HDL-1, free cholesterol HDL-1, phospholipids HDL-1, and Apo-A1 HDL-1) than K3EDTA plasma.  The strength of correlations between levels of lipoproteins were similar among tube types. The authors developed a statistical solution based on regression analysis that once applied partially corrected for tube type-specific differences, which allowed specimens to cluster by patient.

  • Biospecimens

    FluidBlood
    FluidPlasma
    FluidSerum
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    LipoproteinNMR
    Small moleculeNMR
    LipidNMR
    SteroidNMR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    None
    Sodium EDTA
    Sodium citrate
    Biospecimen AcquisitionType of collection container/solution
    K3EDTA plasma vacutainer tube
    Serum tubes with gel separator and clot activator
    Trisodium citrate plasma vacutainer tube
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum